Clinical Trial Update: Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether oral acetazolamide and brimonidine tartrate, with anterior chamber paracentesis, can reduce ocular hypertension after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy

Drugs mentioned

• ALPHAGAN P (BRIMONIDINE TARTRATE)
• Avastin (bevacizumab)
• Diamox (acetazolamide)

Snippet

Sponsor: University of Sao Paulo | Conditions: Age Related Macular Degeneration, Diabetic Retinopathy | Phase 2 | Status: COMPLETED